Skip to content
Stop using now Drug recall · FDA · Published April 23, 2015

Hospira Recalls Bupivacaine Vials Due to Iron Oxide Particles

Hospira Inc. recalls 150,950 vials of Bupivacaine Hydrochloride Injection due to the presence of iron oxide particles.

🇺🇸 FDA recall #D-1216-2015DrugHospira ›
Take action

Contact the company

Recalling firmHospira Inc.600 N Field Dr · Lake Forest, IL 60045-4835
✎ GovInfoNow plain-language explainer

Hospira Inc. is recalling 150,950 single-use vials of Bupivacaine Hydrochloride Inj., USP because they contain free-floating and embedded iron oxide particles. This defect was found in vials distributed nationwide before the recall date. The specific lot affected has an expiry date of February 1, 2016. Read more at govinfonow.com/recall/44742-hospira-inc-recalls-bupivacaine-hydrochloride-inj-usp-0-5-5.

Source Summary by GovInfoNow · govinfonow.com/recall/44742-hospira-inc-recalls-bupivacaine-hydrochloride-inj-usp-0-5-5 · Updated October 12, 2026 · FDA enforcement record: FDA #D-1216-2015

Cite this page

“Hospira Recalls Bupivacaine Vials Due to Iron Oxide Particles.” GovInfoNow, updated October 12, 2026. https://govinfonow.com/recall/44742-hospira-inc-recalls-bupivacaine-hydrochloride-inj-usp-0-5-5. Based on FDA recall #D-1216-2015 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1216-2015%22&limit=1).

The FDA announced on April 23, 2015, that Hospira Inc. is recalling Bupivacaine Hydrochloride Injections due to the presence of iron oxide particles. The agency classified the recall as Class I.

How to tell if you have it

  • Brand: Hospira
  • Product: Bupivacaine Hydrochloride Inj., USP, 0.5% (5 mg/mL), Preservative-Free, 30 mL Single Use Vials, Rx only
  • NDC: 0409-1162-02
  • Lot #: 38-515-DK
  • Expiry: 1 FEB 2016

The hazard

The recall addresses the presence of free-floating and embedded iron oxide particles in the product. The FDA listed this as a Class I hazard.

Context

GovInfoNow's records show Hospira Inc. has 108 other recalls on record since April 5, 2012. Other recent recalls of similar products include Asteria Health ESTRADIOL 20mg Pellet Recall (Jan. 26, 2026), Taro Recalls Children's Ibuprofen Due to Foreign Substance (March 2, 2026), and Asteria Health ESTRADIOL Pellets Recall (Jan. 26, 2026).

How to tell if you have this one

Check for Bupivacaine Hydrochloride Inj., USP, 0.5% (5 mg/mL), Preservative-Free, 30 mL Single Use Vials. Look for NDC 0409-1162-02 and Lot # 38-515-DK with an expiry date of 1 FEB 2016.

  • Brand
    Hospira
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Stop Using the Product

    Do not use any vials that match the recalled NDC and lot number due to the risk of particulate contamination.

  2. Contact Your Supplier

    Reach out to your pharmaceutical distributor or Hospira Inc. for instructions on returning or disposing of the product.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “U.S. Nationwide including Guam.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 9 months after the firm started it.

1. Firm started the recall: Apr 23, 201512. FDA classified it Class I: Jul 8, 201523. Published in FDA’s Enforcement Report: Jul 15, 201534. FDA terminated the recall: Jan 26, 2016420152016
  1. Firm started the recall
  2. FDA classified it Class I
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

Where was this product distributed?

The product was distributed nationwide in the U.S., including Guam.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1216-2015 (April 23, 2015) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1216-2015 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 12, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA